| ST003410 Lipidomics Analysis of ER+ Breast Cancer Cells Treated with Giredestrant and Palbociclib | ||||
| Limit by pathway class: | ||||
| Pathway name (# of metabolites detected in this study) | HMDB pathway | KEGG pathway |
|---|---|---|
| Glycerolipid Metabolism (410) | SMP0000039 | map00561 |
| Phospholipid Biosynthesis (289) | SMP0000025 | map00564 |
| Sphingolipid Metabolism (42) | SMP0000034 | map00600 |
| Steroid Biosynthesis (21) | SMP0000023 | map00100 |
